Autocrine interaction between IL-5 and IL-1β mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle

Journal of Clinical Investigation

Volumn 104, Issue 5, 1999, Pages 657-667

  Hakonarson, Hakon ^a   Maskeri, Neil ^a   Carter, Carrie ^a   Chuang, Sing ^a   Grunstein, Michael M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR BLOCKING ANTIBODY; NEUTRALIZING ANTIBODY; RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RESPIRATORY TRACT MUCOSA; RNA ANALYSIS;

EID: 0032699292     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7137     Document Type: Article

References (37)

1. Bai, T.R. 1990. Abnormalities in airway smooth muscle in fatal asthma. Am. Rev. Respir. Dis. 141:552-557.
2. Goldie, R.G., Spina, D., Henry, P.J., Lulich, K.M., and Paterson, J.W. 1986. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br. J. Clin. Pharmacol. 22:669-676.
3. Bousquet, J., et al. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
4. Djukanovic, R., et al. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434-457.
5. Koning, H., Neijens, H.J., Baert, M.R., Oranje, A.P., and Savelkoul, H.F. 1997. T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine. 9:427-436.
6. Gascan, H., et al. 1991. Regulation of human IgE synthesis. Clin. Exp. Allergy. 21(Suppl. 1):162-166.
7. Romagnani, S. 1995. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:121-129.
8. Tavernier, J.H., et al. 1996. In Hematopoetic cell growth factors and their receptors. A.D. Whetton and J. Gordon, editors. Plenum Press. New York, NY. 321-361.
9. Shimoda, K., et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380:630-633.
10. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
11. Hall, L.R., Mehlotra, R.K., Higgins, A.W., Haxhiu, M.A., and Pearlman, E. 1998. An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness. Infect. Immun. 66:4425-4430.
12. Till, S.J., et al. 1998. Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge. Am. J. Respir. Crit. Care Med. 158:404-411.
13. Stadnyk, A.W. 1994. Cytokine production by epithelial cells. FASEB J. 8:1041-1047.
14. Luger, T.A., et al. 1990. Cytokines and the skin. Curr. Probl. Dermatol. 19:35-49.
15. Jordana, M., Sarnstrand, B., Sime, P.J., and Ramis, I. 1994. Immune-inflammatory functions of fibroblasts. Eur. Respir. J. 7:2212-2222.
16. Barker, J.N., Mitra, R.S., Griffiths, C.E., Dixit, V.M., and Nickoloff, B.J. 1991. Keratinocytes as initiators of inflammation. Lancet. 337:211-214.
17. Hakonarson, H., Herrick, D.J., Serrano, P.G., and Grunstein, M.M. 1997. Autocrine role of interleukin 1beta in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 99:117-124.
18. Hakonarson, H., Maskeri, N., Carter, C., and Grunstein, M.M. 1999. Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 103:1077-1087.
19. Hakonarson, H., Herrick, D.J., and Grunstein, M.M. 1995. Mechanism of impaired beta-adrenoceptor responsiveness in atopic sensitized airway smooth muscle. Am. J. Physiol. 269:L645-L652.
20. Hakonarson, H., and Grunstein, M.M. 1998. Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. 95:5257-5262.
21. Campbell, H.D., et al. 1987. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc. Natl. Acad. Sci. USA. 84:6629-6633.
22. Conlon, P.J., III, Cosman, D.J., Grabstein, D.J., Mopp, T.P., Kronham, S.R., Larsen, A.D., March, C.J., Price, V.L., and Current, D.P., inventors. Gene encoding biologicallyactive human interleukin 1. US patent 5,122,459. Issued June 16, 1992.
23. Seshadri, T., Uzman, J.A., Oshima, J., and Campisi, J. 1993. Identification of a transcript that is down-regulated in senescent human fibroblasts. Cloning, sequence analysis, and regulation of the human L7 ribosomal protein gene. J. Biol. Chem. 268:18474-18480.
24. Watson, M.L., Smith, D., Bourne, A.D., Thompson, R.C., and Westwick, J. 1992. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 8:365-369.
25. Wills-Karp, et al. 1993. Organ culture with proinflammatory cytokines reproduces impairment of the beta-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am. J. Respir. Cell Mol. Biol. 8:153-159.
26. Hakonarson, H., Herrick, D.J., Serrano, P.G., and Grunstein, M.M. 1996. Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle. J. Clin. Invest. 97:2593-2600.
27. Robinson, D.S., et al. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
28. Walker, C., et al. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
29. Ackerman, V., et al. 1994. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest. 105:687-696.
30. Hamid, Q., et al. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
31. Ying, S., Durham, S.R., Corrigan, C.J., Hamid, Q., and Kay, A.B. 1995. Phenotype of cells expressing mRNA for TH2-rype (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477-487.
32. Robinson, D., et al. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.
33. Umetsu, D.T., and DeKruyff, R.H. 1997. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases [review]. Proc. Soc. Exp. Biol. Med. 215:11-20.
34. Zangrilli, J.G., et al. 1995. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am. J. Respir. Crit. Care Med. 151:1346-1353.
35. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
36. Lee, J.J., et al. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143-2156.
37. Mathur, M., et al. 1999. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am. J. Respir. Crit. Care Med. 159:580-587.